| Ceftolozane/tazobactam | Piperacillin/tazobactam | Incremental Ceftolozane/tazobactam - Piperacillin/tazobactam |
---|---|---|---|
Total costs per patient (USD 2015) | $36,413 | $36,028 | $385 |
Total QALYs (undiscounted) per patient | 11.82 | 11.74 | 0.08 |
Total QALYs (discounted) per patient | 9.19 | 9.13 | 0.06 |
Incremental Cost Effectiveness Ratio (Cost per discounted QALY gained) | Â | Â | $6128 |
Hospitalization days saved per patient | Â | Â | 0.25 |